» Articles » PMID: 35884562

UFMylation System: An Emerging Player in Tumorigenesis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Jul 27
PMID 35884562
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitin-fold modifier 1 (UFM1), a newly identified ubiquitin-like molecule (UBLs), is evolutionarily expressed in multiple species except yeast. Similarly to ubiquitin, UFM1 is covalently attached to its substrates through a well-orchestrated three-step enzymatic reaction involving E1, the UFM1-activating enzyme (ubiquitin-like modifier-activating enzyme 5, UBA5); E2, the UFM1-conjugating enzyme 1 (UFC1); and E3, the UFM1-specific ligase 1 (UFL1). To date, numerous studies have shown that UFM1 modification is implicated in various cellular processes, including endoplasmic reticulum (ER) stress, DNA damage response and erythroid development. An abnormal UFM1 cascade is closely related to a variety of diseases, especially tumors. Herein, we summarize the process and functions of UFM1 modification, illustrating the relationship and mechanisms between aberrant UFMylation and diversified tumors, aiming to provide novel diagnostic biomarkers or therapeutic targets for cancer treatments.

Citing Articles

Systematic Analysis of UFMylation Family Genes in Tissues of Mice with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Jiang M, Zhang C, Zhang Z, Duan Y, Qi S, Zeng Q Genes (Basel). 2025; 16(1.

PMID: 39858578 PMC: 11765366. DOI: 10.3390/genes16010031.


The UFMylation pathway is impaired in Alzheimer's disease.

Yan T, Heckman M, Craver E, Liu C, Rawlinson B, Wang X Mol Neurodegener. 2024; 19(1):97.

PMID: 39696466 PMC: 11656649. DOI: 10.1186/s13024-024-00784-y.


Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1-Mediated Activation of NF-κB Signaling.

Guo X, Yang F, Liu T, Chen A, Liu D, Pu J Adv Sci (Weinh). 2024; 11(45):e2401672.

PMID: 39405202 PMC: 11615765. DOI: 10.1002/advs.202401672.


Role of UFMylation in tumorigenesis and cancer immunotherapy.

Ding L, Jiang X, Li T, Wang S Front Immunol. 2024; 15:1454823.

PMID: 39247188 PMC: 11377280. DOI: 10.3389/fimmu.2024.1454823.


The UFMylation pathway is impaired in Alzheimer's disease.

Yan T, Heckman M, Craver E, Liu C, Rawlinson B, Wang X bioRxiv. 2024; .

PMID: 38903110 PMC: 11188091. DOI: 10.1101/2024.05.24.595755.


References
1.
Xi P, Ding D, Zhou J, Wang M, Cong Y . DDRGK1 regulates NF-κB activity by modulating IκBα stability. PLoS One. 2013; 8(5):e64231. PMC: 3651127. DOI: 10.1371/journal.pone.0064231. View

2.
Sun Z, Brodsky J . Protein quality control in the secretory pathway. J Cell Biol. 2019; 218(10):3171-3187. PMC: 6781448. DOI: 10.1083/jcb.201906047. View

3.
Kim T, Croce C . MicroRNA and ER stress in cancer. Semin Cancer Biol. 2021; 75:3-14. DOI: 10.1016/j.semcancer.2020.12.025. View

4.
Yoo H, Kang S, Kim J, Lee J, Seong M, Lee S . Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. Mol Cell. 2014; 56(2):261-274. DOI: 10.1016/j.molcel.2014.08.007. View

5.
Zheng M, Gu X, Zheng D, Yang Z, Li F, Zhao J . UBE1DC1, an ubiquitin-activating enzyme, activates two different ubiquitin-like proteins. J Cell Biochem. 2008; 104(6):2324-34. DOI: 10.1002/jcb.21791. View